![](/img/cover-not-exists.png)
QoL analyses from INFORM study, a phase III study of gefitinib versus placebo as maintenance therapy in advanced NSCLC
Yang, Yun-Peng, Ma, Yu-Xiang, Huang, Yan, Zhao, Yuan-Yuan, Fang, Wen-Feng, Hong, Shao-Dong, Tian, Ying, Xue, Cong, Sheng, Jin, Zhang, LiVolume:
5
Language:
english
Journal:
Scientific Reports
DOI:
10.1038/srep11934
Date:
July, 2015
File:
PDF, 1.04 MB
english, 2015